This volume provides a comprehensive overview of critical care of the pediatric immunocompromised hematology-oncology patient. The text focuses on unique aspects of the pediatric immunocompromised patient that predisposes the child to significant illness, and presents critical care management strategies specific to the patient population. In addition to chapters on oncology, primary immune deficiency, immunocompromised hematology, and hematopoietic cell transplant patients, the book covers the changing landscape of ICU care, pharmacologic considerations, and psychological and social aspects of the critical care of hematology-oncology patients.

Written by experts from a range of disciplines, Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient: An Evidence-Based Guide is a valuable resource for clinicians and practitioners who treat this patient population.

This book covers all key aspects of critical care in pediatric nephrology, including acute dialysis in sick children. It also provides detailed protocols for managing fluid and electrolyte balance and dialysis in children in intensive care. In addition, this quick guide discusses innovations in pediatric renal replacement therapy technologies, such as plasma exchange, CARPEDIEM, NIDUS and aquadex. This is a go-to book for intensivists, physicians and trainees working in pediatric intensive care units.

This book provides readers with a comprehensive evaluation of paediatric radiographs in preparation for the demanding Rapid Reporting component of the Fellowship of the Royal College of Radiologists (FRCR) Part 2B examination, where the margin between pass and fail is very narrow. While other resources may include only a handful of paediatric images in a practice reporting packet, this book is dedicated solely to improving paediatric reporting skill and knowledge. It is designed to address an important deficiency identified in the FRCR Part 2B Examiners’ Report, in that “many candidates struggle with interpretation of paediatric imaging – even for common paediatric pathologies”. The ten practice tests presented, each with 30 images, will assist readers not only in passing the examination but also in the real world when they have to report paediatric radiographs independently. The range of cases covered, from neonate to adolescent, delivers a sound knowledge of both common paediatric fracture patterns and patterns which are subtler but require a definitive answer as to whether they are normal or abnormal. Guidance is also provided on how to describe each abnormality.

This best-selling and widely used resource on pediatric antimicrobial therapy provides instant access to reliable, up-to-the-minute recommendations for treatment of all infectious diseases in children.

For each disease, the authors provide a commentary to help health care providers select the best of all antimicrobial choices. Drug descriptions cover pediatric-appropriate antimicrobials and include complete information about dosing regimens. In response to growing concerns about overuse of antibiotics, the program includes guidelines on when not to prescribe antibiotics.

Now in color to help you find the best options quickly!

New in the 25th edition:

• Includes recommendations for new intravenous broad-spectrum beta-lactam/beta-lactamase inhibitor combinations.
• Provides options for treatment of increasing resistance in Escherichia coli for urinary tract infections.
• Includes updates for management of diarrhea, including recommendations for Giardia with tinidazole and nitazoxanide as drugs of choice, based on the new Infectious Diseases Society of America (IDSA) guidelines.
• Clarifies specific, new, and evolving recommendations about antifungal therapeutic drug levels for several invasive fungal infections, particularly in immunocompromised children.
• Reorganizes antiviral table for easier reading: common viral pathogens are in one table and HIV, hepatitis B, and hepatitis C are in a second table.
• Provides guidance for neonates during the ongoing cefotaxime shortage, including alternatives to achieve similar antibacterial activity in similar tissue sites, with a similar safety profile.
• Includes updates, such as new information on drug therapy and steroid therapy for neurocysticercosis, incorporating the new IDSA and American Society of Tropical Medicine and Hygiene guidelines.
• Incorporates new IDSA coccidioidomycosis guidelines in updated recommendations.
• Simplifies navigation with color-coded tabs and tables that make it easier to find the best treatment options for susceptibility of bacterial, fungal, viral, and parasitic pathogens.